Doctor of Medicine

Four Renowned Medical Doctors Join Forces to Launch MDbio, Patient-Tested Plant-Based Medicines Targeting Common Ailments

Retrieved on: 
Tuesday, March 22, 2022
CBC, GABA, DPM, Quercetin, Foot, Doctor of Medicine, Food, Pain, Health, Industry, Vitamin, Gastroenterology, CBG, CBN, Zinc, Regulation of food and dietary supplements by the U.S. Food and Drug Administration, GLOBE, Physician, Solution, Hepatology, Anxiety, Ankle, American Academy of Otolaryngology–Head and Neck Surgery, Organic acid, Doctor, Patient, Disease, FACS, Pharmaceutical industry, Dietary supplement, MD, CBD

Los Angeles, March 22, 2022 (GLOBE NEWSWIRE) -- MDbio , The Doctors Brand committed to providing therapeutic plant-based medicines, today announced its official launch.

Key Points: 
  • Los Angeles, March 22, 2022 (GLOBE NEWSWIRE) -- MDbio , The Doctors Brand committed to providing therapeutic plant-based medicines, today announced its official launch.
  • Founded by four renowned medical doctors inSouthern California, with over 80 combined years of patient care, MDbio combines the best of modern science with holistic remedies through medical-grade, patient-tested Full Spectrum Hemp + high-potency botanical products.
  • MDbio originates with four Board-Certified Medical Doctors whose career-long mission has been to maximize positive patient outcomes and minimize harm.
  • All MDBio products are now available on mdbiowellness.com and can be purchased in 10, 30 or 60 count quantities for$14.95$74.95.

URGENT CARE 24/7 ANNOUNCES THE OPENING OF BULLDOG DENTAL CARE 24/7 IN THE HEART OF ATHENS, GEORGIA

Retrieved on: 
Tuesday, March 15, 2022
Insurance, Dental care, Urgent care center, MD, University, Moses H. Cone Memorial Hospital, Orthodontics, Patient, Doctor of Medicine, Wake Forest Baptist Medical Center, GA, Baxter Street, Internal medicine, Primary health care, Medical college, Medical College of Georgia, Moses, Television, Dental, Heart, UGA, Medicine, Bulldog, Health insurance, Hospital, Dentistry

ATHENS, Ga., March 15, 2022 /PRNewswire/ -- Urgent Care 24/7, with clinics in five states nationwide, announced today the opening of its newest dental facility in Athens, Georgia. Appropriately named Bulldog Dental Care 24/7, the new facility will be located next to its popular Bulldog Urgent Care in the heart of Athens at 494 Baxter Street Suite B. Bulldog Dental is conveniently located to serve the college community for both emergency and general treatment.  

Key Points: 
  • Co- Located with Bulldog Urgent Care, Bulldog Dental Care is Open for Emergency Walk-in Care and New Dental Patients
    ATHENS, Ga., March 15, 2022 /PRNewswire/ -- Urgent Care 24/7, with clinics in five states nationwide, announced today the opening of its newest dental facility in Athens, Georgia.
  • Appropriately named Bulldog Dental Care 24/7, the new facility will be located next to its popular Bulldog Urgent Care in the heart of Athens at 494 Baxter Street Suite B. Bulldog Dental is conveniently located to serve the college community for both emergency and general treatment.
  • As its name indicates, Bulldog Dental Care caters to the university crowd, with its Bulldog themed waiting room and large screen TVs.
  • Founded by Dr. Jerry Williams, MD, Urgent Care 24/7 and Dental Care 24/7 are dedicated to excellence and offer affordable care when patients need it most.

URGENT CARE 24/7 ANNOUNCES THE OPENING OF ITS NEWEST WALK-IN CLINIC IN CHARLOTTE, NORTH CAROLINA

Retrieved on: 
Tuesday, March 15, 2022
Insurance, Dental care, Urgent care center, MD, Moses H. Cone Memorial Hospital, Patient, Doctor of Medicine, Wake Forest Baptist Medical Center, COVID-19, Internal medicine, STD, Primary health care, Medical college, Moses, Dental, Medicine, B-12, COVID-19 testing, X-ray, Hospital

CHARLOTTE, N.C., March 15, 2022 /PRNewswire/ -- Urgent Care 24/7, with clinics in 5 states nationwide, announced today the opening of its newest facility in Charlotte, North Carolina.

Key Points: 
  • CHARLOTTE, N.C., March 15, 2022 /PRNewswire/ -- Urgent Care 24/7, with clinics in 5 states nationwide, announced today the opening of its newest facility in Charlotte, North Carolina.
  • Urgent Care 24/7 Charlotte is now open to patients without an appointment, and services are provided 24 hours a day, 7 days a week, 365 days a year.
  • Urgent Care 24/7 Charlotte is conveniently located on1726 E. 7th Street.Treatments and procedures include urgent care; cold, flu and illness care; wound care; X-Rays; ultrasound; full-service lab testing (includingurgent care walk-in COVID-19 testing); drug and alcohol testing; physical exams; drug screens; STD testing; flu shots; B-12 shots and hydration therapy.
  • Founded by Dr. Jerry Williams, MD, Urgent Care 24/7 and Dental Care 24/7 are dedicated to excellence and offer affordable care when patients need it most.

Dr. Nalini Rajamannan's publishes her new book: The Final FDA Revelations, a Victory for U.S. Citizens available on Barnes and Nobel March 14, 2022

Retrieved on: 
Monday, March 14, 2022
Notre Dame, Internal medicine, Chicago, University, Criticism of the Food and Drug Administration, Cathedral of the Most Sacred Heart of Jesus (Knoxville, Tennessee), Physician, Chicago Sun-Times, NBC, FDA, Doctor of Medicine, Noble, Judiciary committee, Chicago Tribune, Mayo Clinic Alix School of Medicine, Multimedia, Patient, CBS, Cardiology, Ranking, NIH, Final, Mayo Clinic, Valvular heart disease, West Side, Clinical professor, Food, Northwestern University, Lakeside, United States Senate Finance Subcommittee on International Trade, Customs, and Global Competitiveness, Associate, Barnes, Pharmaceutical industry, Medicine

Also covered in letters sent and received by Honorable Senator Charles Grassley (IA) from 2008 - 2014 , while he was the Ranking member of the Senate Finance and Judiciary Committees.

Key Points: 
  • Also covered in letters sent and received by Honorable Senator Charles Grassley (IA) from 2008 - 2014 , while he was the Ranking member of the Senate Finance and Judiciary Committees.
  • Dr. Nalini Rajamannan is a heart valve expert in the field of cardiovascular medicine.
  • She also worked at the Mayo Clinic as a staff consultant in Internal Medicine and an Associate Professor of Medicine at Northwestern University and the Lakeside and Westside VA.
  • Currently, she practices consultative valvular medicine and Osteocardiology at Most Sacred Heart of Jesus Cardiology and Valvular Institute, WI.

Four Renowned Medical Doctors Join Forces to Launch MDbio, Patient-Tested Plant-Based Medicines Targeting Common Ailments

Retrieved on: 
Wednesday, March 2, 2022
FACS, Regulation of food and dietary supplements by the U.S. Food and Drug Administration, Patient, Anxiety, Ankle, Industry, Food, Foot, Doctor of Medicine, Solution, Gastroenterology, Organic acid, Vitamin, Disease, Pain, Health, CBC, GABA, CBN, Quercetin, CBG, Physician, Zinc, American Academy of Otolaryngology–Head and Neck Surgery, Hepatology, DPM, Pharmaceutical industry, Dietary supplement, CBD, MD

LOS ANGELES, March 2, 2022 /PRNewswire/ -- MDbio , The Doctors Brand committed to providing therapeutic plant-based medicines, today announced its official launch.

Key Points: 
  • LOS ANGELES, March 2, 2022 /PRNewswire/ -- MDbio , The Doctors Brand committed to providing therapeutic plant-based medicines, today announced its official launch.
  • Founded by four renowned medical doctors in Southern California, with over 80 combined years of patient care, MDbio combines the best of modern science with holistic remedies through medical-grade, patient-tested Full Spectrum Hemp + high-potency botanical products.
  • MDbio originates with four Board-Certified Medical Doctors whose career-long mission has been to maximize positive patient outcomes and minimize harm.
  • Targeting ailments such as poor sleep, anxiety, pain, and weakened immune systems, MDbio products naturally restore the body's endocannabinoid balance to maximize overall health and wellbeing in patients.

Rubi Laboratories raises $4.5m in seed funding to supply major fashion brands with carbon-negative textiles

Retrieved on: 
Wednesday, February 16, 2022
CO2, Doctor of Medicine, Climax, Collaborative Fund, Business, Time, Lyft, Textile, CEO, Mirwais Neeka University, Computational neuroscience, Sustainability, Entrepreneurship, Autodesk, Carbon, Bebe Stores, Biological engineering, Enzyme, SAN, Rayon, Wood, Dorm Room Fund, Potyvirus, Goal, Parity, Technology, Airbnb, Lawrence Berkeley National Laboratory, University of California, Berkeley, UC, Uber, Cellulose, Food, Johns Hopkins University, TikTok, Rubí, Plant, Research, Plug and play, Associate, Harvard Medical School, Plug, Mike Hopkins (basketball), Photosynthesis, National Science Foundation, Industry, Renewable energy, Grand

SAN FRANCISCO, Feb. 16, 2022 /PRNewswire-PRWeb/ --Today, Rubi Laboratories the pioneer in carbon-negative cellulosic textiles announces it has raised $4.5m in seed funding.

Key Points: 
  • SAN FRANCISCO, Feb. 16, 2022 /PRNewswire-PRWeb/ --Today, Rubi Laboratories the pioneer in carbon-negative cellulosic textiles announces it has raised $4.5m in seed funding.
  • The funding will enable Rubi's R&D and commercialization to meet the textile needs of major fashion brands.
  • Founded in 2020 by Neeka and Leila Mashouf, Rubi Laboratories is pioneering the creation of carbon negative cellulosic textiles through its patent-pending, cell-free biocatalytic process, starting with viscose.
  • Roughly 35% of major fashion brands' SKUs are made from viscose, a statistic forecasted to grow 8% every year until 2025.

Basem Goueli is Recognized by Continental Who's

Retrieved on: 
Saturday, February 5, 2022
Business administration, Luke the Evangelist, AstraZeneca, Mayo Clinic College of Medicine and Science, Artificial intelligence, UNC, Precision medicine, Oncology, Master of Business Administration, University, Blueprint, Algorithm, Internal medicine, Doctor of Medicine, Research, St Luke's, Clinical trial, The New England Journal of Medicine, Buffalo buffalo Buffalo buffalo buffalo buffalo Buffalo buffalo, Hospital, National, Empathy, Publication, Regional Cancer Centre, Thiruvananthapuram, Covenant, Stanford University, Continental, Associate, CEO, Health care, Chapel Hill, MIT, Doctorate, Janssen, Doctor of Philosophy, Machine learning, MD, Buffalo, George Washington University, University of North Carolina at Pembroke, MBA, Medicine, Medical device, Lancet, Hematology, Science, Medicine, Genentech, Biochemistry

EAST AMHURST, N.Y., Feb. 4, 2022 /PRNewswire/ -- Basem Goueli, MD, Ph.D., MBA, is being recognized by Continental Who's Who as aDistinguished CEOin the Healthcare field and in acknowledgment of his work at CancerLight, CancerClarity, and Xbiotech.

Key Points: 
  • EAST AMHURST, N.Y., Feb. 4, 2022 /PRNewswire/ -- Basem Goueli, MD, Ph.D., MBA, is being recognized by Continental Who's Who as aDistinguished CEOin the Healthcare field and in acknowledgment of his work at CancerLight, CancerClarity, and Xbiotech.
  • Basem Goueli is a seasoned healthcare professional and executive who recently started two medical businesses, CancerLight and CancerClarity.
  • Dr. Goueli completed a Bachelor of Science in Biochemistry/Genetics/Cell Biology at the University of Minnesota in 1996.
  • Dr. Goueli did his fellowship in Hematology and Medical Oncology and post-doctoral fellowship in biochemistry at Stanford University from 2008-2012.

GraceMed Welcomes "Dr. Reza" Ahmadzadeh As Surgical Associate

Retrieved on: 
Thursday, January 20, 2022
Patient, American Society of Plastic Surgeons, FRCSC, Plastic surgery, Doctor of Medicine, Mastopexy, Class, Health, Cosmetic, Plastic, Breast augmentation, Faculty, Memorial University of Newfoundland, Education, University, MD, NYC Surgical Associates, Dermatology, Microsurgery, Family, GTA, Private practice, Dentistry, Medicine, BURLINGTON, Medicine, Hand

Dr. Reza made both the personal and professional decision to move to Ontario to be closer to his family in the GTA, and to pursue the Surgical Associate opportunity at GraceMed Burlington.

Key Points: 
  • Dr. Reza made both the personal and professional decision to move to Ontario to be closer to his family in the GTA, and to pursue the Surgical Associate opportunity at GraceMed Burlington.
  • Dr. Reza is an accomplished surgeon, and brings his years of expertise in cosmetic medicine and masterful surgical techniques to the GraceMed surgical team.
  • Therefore, my goal is to provide everyone with surgical and non-surgical options that best suits their aesthetic needs," says Dr. Reza.
  • He founded GraceMed on the pillars of excellent patient care, the highest surgical standards, a professional environment, and compassionate staff.

DiaMedica Therapeutics Appoints Dr. Kirsten Gruis as Chief Medical Officer

Retrieved on: 
Wednesday, January 5, 2022
FDA, Health, Clinical Trials, Pharmaceutical, Cardiology, Biotechnology, KLK1, Medicine, Therapy, COVID-19, University, Chronic kidney disease, Kidney, Form 10-K, Vascular dementia, School, Oxidative stress, Company, Stroke, Patient, State University of New York Upstate Medical University, Pi1 Gruis, Fibrosis, Lists of diseases, U.S. Securities and Exchange Commission, Public health, Pfizer, Neurogenesis, CEO, Hypertension, Clinical trial, AIS, FDA, Inflammation, Private Securities Litigation Reform Act, DMAC, Grinnell College, Retinopathy, Terminology, Employment, Associate, Risk, Doctor of Medicine, Drug development, Nasdaq, Standard of care, Nitric oxide, Annual report, Urine, Iowa State University, Roche, Nature, Pharmaceutical industry, Science, Microbiology, DM199, DiaMedica Therapeutics Inc., DM199, DIAMEDICA THERAPEUTICS INC.

DiaMedica Therapeutics Inc. (Nasdaq: DMAC), a clinical-stage biopharmaceutical company focused on developing novel treatments for neurological disorders and kidney diseases, announced today the appointment of Kirsten Gruis, M.D.

Key Points: 
  • DiaMedica Therapeutics Inc. (Nasdaq: DMAC), a clinical-stage biopharmaceutical company focused on developing novel treatments for neurological disorders and kidney diseases, announced today the appointment of Kirsten Gruis, M.D.
  • We are delighted to welcome Dr. Gruis to the DiaMedica team as Chief Medical Officer, said Rick Pauls, CEO of DiaMedica.
  • Prior to joining DiaMedica, Dr. Gruis served as Chief Medical Officer for Edgewise Therapeutics, Neuromuscular Franchise Head at Roche, Chief Medical Officer of Agilis Biotherapeutics, Inc. and a number of additional senior clinical development roles at companies including Wave Life Sciences Ltd., Idera Pharmaceutics, Inc., Alynylam Pharmaceuticals Inc. and Pfizer Inc.
  • DiaMedica Therapeutics Inc. is a clinical stage biopharmaceutical company committed to improving the lives of people suffering from serious diseases.

Avra, Inc. Completes its Merger with Springs Rejuvenation, LLC, a Stem Cell and Anti-Aging Treatment Company

Retrieved on: 
Monday, December 20, 2021
FINRA, GLOBE, Corporate action, PRP, Rejuvenation, FDA, High Desert State Prison (Nevada), Regenerative medicine, OTC Markets Group, ALS, 21st Street station (IND Crosstown Line), Lupus, NYU Langone Hospital – Brooklyn, OTC, Inflammation, Cell, Injection, Stroke, Autoimmunity, COPD, Heart failure, Doctorate, Company, Multiple sclerosis, Avra, Immune system, Cornell University, B cell, Consolidated, Doctor of Medicine, Patient, LLC, Parkinson's disease, Pharmaceutical industry

The surviving entity will be Springs Rejuvenation, Inc. (SPRINGS), a Chamblee, Georgia anti-aging and stem cell center focusing on stem cell therapy, facial rejuvenation, hair rejuvenation, non-surgical hair restoration, protein rich plasma (PRP) injections, and anti-aging treatments.

Key Points: 
  • The surviving entity will be Springs Rejuvenation, Inc. (SPRINGS), a Chamblee, Georgia anti-aging and stem cell center focusing on stem cell therapy, facial rejuvenation, hair rejuvenation, non-surgical hair restoration, protein rich plasma (PRP) injections, and anti-aging treatments.
  • SPRINGS was founded and incorporated in the State of Georgia in May of 2019 by Dr. Charles Pereyra.
  • This makes stem cell therapy a viable treatment option for a variety of medical conditions.
  • A primary goal of the merger is to allow SPRINGS to duplicate its model of high-quality stem cell treatments throughout the United States.